FATIMA BARDALES-DELGADO: Open Payments
NPI 1467040998 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 43 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $599 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 9 | $137 |
| GENZYME CORPORATION | 3 | $65 |
| PFIZER INC. | 4 | $64 |
| UCB, Inc. | 3 | $56 |
| Janssen Biotech, Inc. | 3 | $55 |
| Amgen Inc. | 3 | $54 |
| Organon LLC | 4 | $42 |
| Incyte Corporation | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
Products named: ADBRY, DUPIXENT, CIBINQO, Bimzelx, TREMFYA, Otezla, OPZELURA, COSENTYX.
Industry payments across NJ — which companies pay providers there.
